These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 8512332
1. [Treatment results of intra-arterial ACNU infusion chemotherapy for primary cerebral malignant lymphoma]. Hayashi A, Kyuma Y, Chiba Y, Kuwana N, Kojima Y. Gan To Kagaku Ryoho; 1993 Jun; 20(8):1043-7. PubMed ID: 8512332 [Abstract] [Full Text] [Related]
2. Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy. Sonoda Y, Matsumoto K, Kakuto Y, Nishino Y, Kumabe T, Tominaga T, Katakura R. Acta Neurochir (Wien); 2007 Nov; 149(11):1183-9; discussion 1189. PubMed ID: 17712511 [Abstract] [Full Text] [Related]
5. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery. Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA. Cancer J Sci Am; 1998 Nov; 4(2):110-24. PubMed ID: 9532413 [Abstract] [Full Text] [Related]
6. [Management results of primary intracranial malignant lymphoma]. Hayashi A, Kyuma Y, Kuwabara T, Fujitsu K, Shinonaga M, Yamaguchi K, Sekido K, Chiba Y, Yamashita T, Oda M. No Shinkei Geka; 1990 Aug; 18(8):715-20. PubMed ID: 2215864 [Abstract] [Full Text] [Related]
7. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption]. Yamada K, Takahama H, Nakai O, Takanashi T, Hosoya T. Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817 [Abstract] [Full Text] [Related]
8. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience. Fortin D, Desjardins A, Benko A, Niyonsega T, Boudrias M. Cancer; 2005 Jun 15; 103(12):2606-15. PubMed ID: 15880378 [Abstract] [Full Text] [Related]
9. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis. Fortin D, Gendron C, Boudrias M, Garant MP. Cancer; 2007 Feb 15; 109(4):751-60. PubMed ID: 17211866 [Abstract] [Full Text] [Related]
10. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol]. Miyagami M, Kagawa Y, Tsubokawa T. No Shinkei Geka; 1985 Sep 15; 13(9):955-63. PubMed ID: 2999632 [Abstract] [Full Text] [Related]
11. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society. J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063 [Abstract] [Full Text] [Related]
12. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma. Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T. Strahlenther Onkol; 2003 Sep 01; 179(9):626-32. PubMed ID: 14628129 [Abstract] [Full Text] [Related]
13. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26). Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M. BMC Cancer; 2006 Oct 18; 6():247. PubMed ID: 17049083 [Abstract] [Full Text] [Related]
14. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Dahlborg SA, Henner WD, Crossen JR, Tableman CM, Petrillo A, Braziel R, Neuwelt EA. Cancer J Sci Am; 1996 Oct 18; 2(3):166-74. PubMed ID: 9166517 [Abstract] [Full Text] [Related]
15. Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma. Xue H, Wang H, Kong L, Zhou H. Chin Med J (Engl); 1998 Aug 18; 111(8):751-3. PubMed ID: 11245034 [Abstract] [Full Text] [Related]
16. [Primary cerebral non-Hodgkin's lymphomas. The results of radiotherapy]. Hetzel-Sesterheim M, Schnabel K, Nestle U, Hamann G, Berberich W. Strahlenther Onkol; 1996 Apr 18; 172(4):198-204. PubMed ID: 8623082 [Abstract] [Full Text] [Related]
17. [Treatment of malignant gliomas by selective intraarterial infusion chemotherapy with high-dose ACNU and autologous bone marrow transplantation--preliminary report]. Nakagawa H, Murasawa A, Taki T, Nakajima S, Niiyama K, Furuta Y, Fujita T, Tsuruzono K, Nakamura H, Shibata H. Gan To Kagaku Ryoho; 1991 Nov 18; 18(14):2435-40. PubMed ID: 1659327 [Abstract] [Full Text] [Related]
18. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N. Ann Hematol; 2005 Apr 18; 84(4):223-6. PubMed ID: 15042316 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma. Zylber-Katz E, Gomori JM, Schwartz A, Lossos A, Bokstein F, Siegal T. Clin Pharmacol Ther; 2000 Jun 18; 67(6):631-41. PubMed ID: 10872645 [Abstract] [Full Text] [Related]
20. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma. Glas M, Hundsberger T, Stuplich M, Wiewrodt D, Kurzwelly D, Nguyen-Huu B, Rasch K, Herrlinger U. Oncology; 2009 Jun 18; 76(3):184-9. PubMed ID: 19218824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]